News
NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback